# 胆红素计市场

> 胆红素计市场研究报告按测量类型（经皮胆红素计、光谱胆红素计、化学试纸胆红素计）、按应用（新生儿筛查、黄疸监测、肝病诊断）、按准确度等级（标准准确度、高准确度）、按便携性（便携式胆红素计、医院内胆红素计）、按患者人群（新生儿、成人、儿童）以及按地区（北美、欧洲、南美、亚太、中东和非洲）- 预测到2035年

- **Forecast Period:** 2025 - 2035
- **CAGR:** 4.24%
- **2024:** $ 750.18 Billion
- **2025:** $ 782 Billion
- **2035:** $ 1,184.77 Billion
- **Key Players:** Philips(NL), Abbott (US), Roche (CH), Medtronic (US), Natus Medical (US), GlucoTrack (IL), Draeger (DE), Bionime (TW), Ameda (US)

**Report ID:** MRFR/HC/29390-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** April 24, 2026

**URL:** https://www.marketresearchfuture.com/reports/bilirubin-meter-market-31160

---

## Market Summary

## **Bilirubin Meter Market Overview**

As per MRFR analysis, the Bilirubin Meter Market Size was estimated at 750.18 (USD Billion) in 2024. The Bilirubin Meter Market Industry is expected to grow from 782.00 (USD Billion) in 2025 to 1,136.56 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 4.24% during the forecast period (2025 - 2034).

### **Key Bilirubin Meter Market Trends Highlighted**

Key Market Drivers The  bilirubin meter market is primarily driven by the increasing prevalence of neonatal jaundice, growing awareness of early detection and treatment of hyperbilirubinemia, and technological advancements in bilirubin measurement devices.Emerging Opportunities Untapped potential exists in emerging markets, where access to healthcare services is improving, and the demand for bilirubin meters is expected to rise.

Additionally, the development of non-invasive and point-of-care bilirubin testing devices creates opportunities for home-based monitoring and early detection in underserved areas.Recent Trends The market has witnessed a shift towards non-invasive bilirubin meters, offering convenience and reducing the discomfort associated with traditional finger prick methods. The adoption of telemedicine and remote patient monitoring systems is also driving the demand for portable and easy-to-use bilirubin meters, facilitating real-time monitoring and remote consultations.

Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Bilirubin Meter Market Drivers**

### Rising Prevalence of Liver Diseases

The increasing prevalence of liver diseases, such as [hepatitis](../../../reports/hepatitis-c-diagnosis-treatment-market-1569), cirrhosis, and jaundice, is a major factor driving the growth of the  bilirubin meter market. These diseases result in elevated levels of bilirubin in the blood, which must be accurately measured to assess the severity of the condition and guide treatment decisions. Bilirubin meters provide a convenient and accurate method for measuring bilirubin levels, making them essential tools in the diagnosis and management of liver diseases.The rising incidence of liver diseases worldwide is expected to continue to drive demand for bilirubin meters in the coming years.

### Technological Advancements

Advancements in technology have played a significant role in the growth of the  bilirubin meter market. The development of non-invasive and portable bilirubin meters has made it easier and more convenient to measure bilirubin levels. These devices can be used in a variety of settings, including hospitals, clinics, and even at home, which has increased their accessibility and usage. Furthermore, the introduction of wireless connectivity and cloud-based data management systems has enabled remote monitoring of bilirubin levels, providing greater convenience and efficiency for healthcare providers and patients.

### Increasing Awareness and Focus on Newborn Health

The growing awareness of the importance of newborn health and the potential risks associated with elevated bilirubin levels in newborns is also contributing to the growth of the  bilirubin meter market. Neonatal jaundice, a condition characterized by high levels of bilirubin in newborns, can lead to serious health problems if left untreated.

Bilirubin meters play a vital role in screening newborns for jaundice and monitoring their bilirubin levels to ensure timely intervention and appropriate treatment.The increasing focus on newborn health and the implementation of screening programs in many countries are expected to drive demand for bilirubin meters in the  Bilirubin Meter Market Industry.

## **Bilirubin Meter Market Segment Insights**

### **Bilirubin Meter Market Measurement Type Insights**

The  Bilirubin Meter Market is segmented based on Measurement Type into Transcutaneous Bilirubin Meters, Spectrophotometric Bilirubin Meters, and Chemical Test Strip Bilirubin Meters. Transcutaneous Bilirubin Meters Transcutaneous bilirubin meters are non-invasive devices that measure bilirubin levels through the skin. They are commonly used for screening newborns for jaundice. The  market for transcutaneous bilirubin meters is expected to grow significantly in the coming years due to the increasing prevalence of jaundice in newborns and the growing awareness of the importance of early detection and treatment.

The market value for transcutaneous bilirubin meters is projected to reach 262.99 USD Billion in 2023 and 372.04 USD Billion in 2032.Spectrophotometric Bilirubin Meters Spectrophotometric bilirubin meters are laboratory-based devices that measure bilirubin levels in blood samples. They are more accurate than transcutaneous bilirubin meters but are also more invasive. The  market for spectrophotometric bilirubin meters is expected to grow steadily in the coming years as the demand for accurate bilirubin testing increases. The market value for spectrophotometric bilirubin meters is projected to reach 279.427 USD Billion in 2023 and 415.224 USD Billion in 2032.

Chemical Test Strip Bilirubin Meters Chemical test strip bilirubin meters are point-of-care devices that measure bilirubin levels in urine samples. They are less accurate than transcutaneous and spectrophotometric bilirubin meters but are also less invasive and less expensive. The growth of the market is attributed to the increasing prevalence of jaundice in newborns, the growing awareness of the importance of early detection and treatment, and the increasing demand for accurate and non-invasive bilirubin testing. The market value for chemical test strip bilirubin meters is projected to reach 147.932 USD Billion in 2023 and 215.916 USD Billion in 2032.

Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Bilirubin Meter Market Application Insights**

The  Bilirubin Meter Market segmentation by application includes Neonatal Screening, Jaundice Monitoring, and Liver Disease Diagnosis. Neonatal screening is the most common application, accounting for over 50% of the market revenue in 2023. The growth of this segment is attributed to the increasing awareness of early detection and treatment of neonatal jaundice, which can lead to severe complications if left untreated. Jaundice monitoring is another significant application, with a market share of around 30% in 2023.

The rising prevalence of liver diseases, such as hepatitis and cirrhosis, is driving the growth of this segment.Liver disease diagnosis, with a market share of approximately 20% in 2023, is expected to witness steady growth due to the increasing adoption of bilirubin meters for the assessment of liver function.

### **Bilirubin Meter Market Accuracy Class Insights**

The  Bilirubin Meter Market is segmented by Accuracy Class into Standard Accuracy and High Accuracy. Standard Accuracy bilirubin meters are widely used in point-of-care settings due to their cost-effectiveness and ease of use. These meters provide accurate results within a clinically acceptable range and are suitable for screening and monitoring bilirubin levels in newborns and infants. The Standard Accuracy segment held a significant market share in 2023 and is expected to maintain its dominance throughout the forecast period.

High Accuracy bilirubin meters offer precise and reliable measurements, making them ideal for critical care settings.These meters are used in hospitals and specialized clinics for precise diagnosis and monitoring of bilirubin levels in patients with severe jaundice or other liver disorders. The High Accuracy segment is projected to grow at a faster pace during the forecast period, driven by the increasing demand for accurate and timely diagnosis of liver diseases.

### **Bilirubin Meter Market Portability Insights**

The  Bilirubin Meter Market is segmented by Portability into Portable Bilirubin Meters and In-Hospital Bilirubin Meters. Portable Bilirubin Meters segment is expected to witness a significant growth over the forecast period. The increasing adoption of portable bilirubin meters in various healthcare settings such as clinics, nursing homes, and home care is driving the growth of this segment. The compact size, portability, and ease of use of portable bilirubin meters make them ideal for point-of-care testing, enabling healthcare professionals to quickly and accurately measure bilirubin levels in patients, leading to timely diagnosis and treatment. 

The In-Hospital Bilirubin Meters segment is anticipated to hold a substantial share in the  Bilirubin Meter Market due to the high demand for accurate and reliable bilirubin measurement in hospital settings. In-hospital bilirubin meters are typically used in neonatal intensive care units (NICUs) and other departments where rapid and precise monitoring of bilirubin levels is crucial for patient care. The advanced features and accuracy of in-hospital bilirubin meters contribute to their wide adoption in hospitals.

### **Bilirubin Meter Market Patient Population Insights**

The patient population segmentation of the  Bilirubin Meter Market holds significant importance in understanding the target audience and their specific healthcare needs. This segmentation is based on age groups, with Neonates, Adults, and Children being the primary categories. Neonates, defined as infants less than 28 days old, constitute a substantial portion of the Bilirubin Meter Market. The prevalence of neonatal jaundice, a condition characterized by elevated bilirubin levels, drives the demand for bilirubin meters in this segment.

According to estimates, the  neonatal jaundice market is projected to reach USD 394.3 million by 2027, highlighting the significant market potential for bilirubin meters catering to newborns.Adults, another crucial segment, represent individuals aged 18 years and above. This segment includes patients with liver disorders such as hepatitis and cirrhosis, which can lead to elevated bilirubin levels. The growing prevalence of liver diseases, coupled with increasing awareness about early diagnosis and monitoring, is expected to fuel the growth of the bilirubin meter market in the adult segment.

Children, ranging from toddlers to adolescents, form the third major patient population segment. Jaundice in children can arise due to various factors, including infections, liver problems, and certain genetic disorders.The market for bilirubin meters in this segment is driven by the need for accurate and non-invasive monitoring of bilirubin levels to ensure timely intervention and prevent complications.

### **Bilirubin Meter Market Regional Insights**

The  Bilirubin Meter Market is segmented into North America, Europe, Asia Pacific, South America, and the Middle East and Africa. North America is the largest market for bilirubin meters, followed by Europe. The Asia Pacific region is expected to grow at the highest CAGR during the forecast period. The growth in the Asia Pacific region is attributed to the increasing demand for bilirubin meters in countries such as China and India. The high prevalence of newborn jaundice in these countries is driving the demand for bilirubin meters.

The market in South America is expected to grow at a moderate pace during the forecast period.The Middle East and Africa region is expected to witness the slowest growth due to the low awareness of bilirubin meters in these regions.

Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Bilirubin Meter Market Key Players And Competitive Insights**

Major players in Bilirubin Meter Market industry are constantly striving to gain a competitive edge by investing in research and development, expanding their product portfolios, and strengthening their distribution channels. Leading Bilirubin Meter Market players are focusing on developing innovative technologies, such as non-invasive and point-of-care bilirubin meters, to meet the evolving needs of healthcare professionals and patients.

The Bilirubin Meter Market is witnessing the emergence of new entrants and the consolidation of existing players, shaping the competitive landscape. Strategic partnerships, mergers, and acquisitions are also driving Bilirubin Meter Market development, as companies seek to expand their  reach and enhance their market position.One of the leading companies in the  Bilirubin Meter Market, GE Healthcare, is known for its advanced and reliable bilirubin meters.

The company's Bilirubinometer JM-105 is widely used in hospitals and clinics worldwide. GE Healthcare focuses on providing innovative solutions that meet the specific needs of healthcare providers, such as accuracy, ease of use, and portability. The company's commitment to research and development has resulted in the development of cutting-edge technologies, including a non-invasive bilirubin meter that offers quick and accurate results.On the other hand, Drager, a leading competitor in the  Bilirubin Meter Market, is recognized for its high-quality and durable bilirubin meters.

The company's Bilirubinometer JM-103 is renowned for its accuracy and reliability, making it a preferred choice for healthcare professionals. Drager places emphasis on providing comprehensive solutions that cater to the diverse requirements of hospitals and clinics. The company's focus on customer satisfaction and technical innovation has enabled it to gain a strong foothold in the market. Drager's commitment to delivering advanced healthcare technologies continues to drive its growth and position it as a formidable competitor in the  Bilirubin Meter Market.

### **Key Companies in the Bilirubin Meter Market Include**

- **[Roche Diagnostics](https://diagnostics.roche.com/global/en/products/lab/bilt3-cps-000050.html)**
- Mindray Medical
- A Medical Corporation
- Biocare International
- Siemens Healthineers
- Jiangsu Zehua Biological Tech
- **[Abbott](https://www.globalpointofcare.abbott/ww/en/product-details/urocolor.html)**
- BioRad Laboratories
- Lhavi Medical Technolgoies
- Instrumentation Laboratory
- Shenzhen Genetron Medical Technology
- EKF Diagnostics
- Nanjing Mega Biotech
- Zhejiang Gongdong Medical Technology
- Shenzhen Uribio Technology

## Bilirubin Meter Market Industry Developments

- **Q2 2024: Konica Minolta Launches New Bilirubin Meter 'BiliCare Pro' for Neonatal Care** Konica Minolta announced the launch of its latest bilirubin meter, 'BiliCare Pro', designed for non-invasive, point-of-care neonatal jaundice screening. The device features enhanced accuracy and wireless data integration for hospital EHR systems.
- **Q1 2024: Natus Medical Announces FDA Clearance for Updated NeoBlue Bilirubin Meter** Natus Medical received FDA clearance for its updated NeoBlue Bilirubin Meter, which offers improved sensitivity and expanded clinical indications for neonatal jaundice monitoring in U.S. hospitals.
- **Q2 2024: Philips Partners with UNICEF to Deploy Bilirubin Meters in Southeast Asia** Philips announced a partnership with UNICEF to supply portable bilirubin meters to rural clinics in Southeast Asia, aiming to improve early detection and treatment of neonatal jaundice in underserved regions.
- **Q3 2024: Dräger Opens New Manufacturing Facility for Medical Devices in Germany** Dräger inaugurated a new manufacturing facility in Lübeck, Germany, dedicated to the production of medical devices including its latest line of bilirubin meters for global distribution.
- **Q2 2024: Advanced Instruments Launches Next-Generation Bilirubin Meter for NICUs** Advanced Instruments introduced a next-generation bilirubin meter tailored for neonatal intensive care units, featuring rapid measurement and improved user interface for clinical staff.
- **Q1 2025: Apel Co., Ltd. Announces Strategic Partnership with Japanese Hospital Network for Bilirubin Meter Deployment** Apel Co., Ltd. entered a strategic partnership with a major Japanese hospital network to deploy its latest bilirubin meters across multiple neonatal care centers.
- **Q2 2025: Reichert Technologies Receives CE Mark Approval for New Transcutaneous Bilirubin Meter** Reichert Technologies obtained CE Mark approval for its new transcutaneous bilirubin meter, enabling commercial sales across the European Union.
- **Q1 2024: GINEVRI Srl Launches Portable Bilirubin Meter for Home Use** GINEVRI Srl launched a portable bilirubin meter designed for home monitoring of neonatal jaundice, targeting parents and pediatricians for early intervention.
- **Q3 2024: Mennen Medical Secures Contract to Supply Bilirubin Meters to Israeli Ministry of Health** Mennen Medical won a government contract to supply bilirubin meters to hospitals and clinics operated by the Israeli Ministry of Health.
- **Q2 2025: Dräger Announces Executive Appointment: New Head of Bilirubin Meter Division** Dräger appointed Dr. Anna Müller as the new head of its Bilirubin Meter Division, overseeing product development and global market strategy.
- **Q1 2025: Advanced Instruments LLC Expands Bilirubin Meter Production Capacity in U.S.** Advanced Instruments LLC announced the expansion of its U.S. production facility to meet growing demand for its bilirubin meters in North America.
- **Q2 2024: Natus Medical Incorporated Wins Supply Contract for Bilirubin Meters with Major U.S. Hospital System** Natus Medical secured a supply contract to provide its bilirubin meters to a major U.S. hospital system, expanding its footprint in neonatal care.

## **Bilirubin Meter Market Segmentation Insights**

### **Bilirubin Meter Market Measurement Type Outlook**

- Transcutaneous Bilirubin Meters
- Spectrophotometric Bilirubin Meters
- Chemical Test Strip Bilirubin Meters

### **Bilirubin Meter Market Application Outlook**

- Neonatal Screening
- Jaundice Monitoring
- Liver Disease Diagnosis

### **Bilirubin Meter Market Accuracy Class Outlook**

- Standard Accuracy
- High Accuracy

### **Bilirubin Meter Market Portability Outlook**

- Portable Bilirubin Meters
- In-Hospital Bilirubin Meters

### **Bilirubin Meter Market Patient Population Outlook**

- Neonates
- Adults
- Children

### **Bilirubin Meter Market Regional Outlook**

- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa

## Market Drivers

### 医疗设备的技术进步

技术创新正在显著影响胆红素计市场行业。先进胆红素计的推出，提供了更高的准确性和用户友好的界面，正在重塑新生儿护理的格局。这些设备通常采用非侵入性测量技术，减少了抽血的需要，最大限度地减轻了婴儿的不适。此外，智能技术的整合允许实时数据分析和远程监测，这可以改善临床决策。随着医疗机构越来越重视以患者为中心的护理，对技术先进的胆红素计的需求预计将上升。这一趋势表明胆红素计市场行业的未来前景光明，因为制造商将继续创新，以满足医疗服务提供者不断变化的需求。

### 医疗基础设施投资上升

持续对医疗基础设施的投资是胆红素计市场行业的重要驱动力。各国政府和私营实体正日益增加资源投入，以改善医疗设施，特别是在发展中地区。这项投资通常包括采购先进的医疗设备，如胆红素计，以提高诊断能力。随着医疗系统的扩展和现代化，对可靠和高效监测工具的需求预计将增长。这一趋势表明胆红素计市场行业的有利环境，因为制造商可能会从增加的订单和寻求升级设备的医疗机构的合作中受益。

### 医疗器械创新的监管支持

监管机构在塑造胆红素计市场行业中发挥着关键作用，促进创新并确保安全。新医疗设备的简化审批流程鼓励制造商开发和推出先进的胆红素计。这种监管支持不仅增强了创新产品的可用性，还增强了医疗服务提供者对这些设备的有效性和安全性的信心。随着法规的演变以适应技术进步，胆红素计市场行业正处于增长的有利位置，越来越多的设备进入市场，以满足对有效黄疸监测解决方案日益增长的需求。

### 日益增长的预防医疗意识

对预防性医疗的日益重视正在推动胆红素计市场行业的增长。随着医疗系统向主动管理健康状况转变，早期发现新生儿黄疸的重要性变得至关重要。家长和医疗专业人员对未治疗黄疸相关风险的认识不断提高，导致对胆红素计的需求增加。这一趋势得到了公共卫生宣传的进一步支持，旨在教育看护者识别黄疸的迹象和症状。因此，胆红素计的市场可能会扩大，因为医疗提供者寻求配备必要的工具，以确保及时干预并改善患者的结果。

### 新生儿黄疸的发病率不断增加

新生儿黄疸发生率的上升是胆红素计市场行业的主要驱动因素。根据健康统计数据，约60%的新生儿会经历某种形式的黄疸，这需要有效的监测解决方案。这种情况的特征是胆红素水平升高，需要及时干预以防止并发症。随着对新生儿健康问题的认识不断提高，医疗服务提供者越来越多地采用胆红素计，以促进早期诊断和治疗。由于医院和诊所寻求改善患者护理并降低与未治疗黄疸相关的严重后果的风险，对这些设备的需求预计将激增。因此，胆红素计市场行业可能会见证显著增长，推动这一增长的因素是对可靠和高效监测工具的需求。

## Future Outlook

胆红素计市场预计将在2024年至2035年间以4.24%的年均增长率增长，推动因素包括技术进步和日益增长的医疗需求。

**New opportunities:**

- 扩展远程胆红素监测的远程医疗服务。
- 便携式胆红素仪的家庭使用开发。
- 与医院合作提供综合胆红素检测解决方案。

到2035年，市场预计将强劲，反映出显著的增长和创新。

## Segment Insights

### 按测量类型：经皮胆红素计（最大）与分光光度胆红素计（增长最快）

在胆红素计市场中，分享分布突显了经皮胆红素计作为主导力量，因其非侵入性的方法和易用性而受到青睐。该细分市场占据了市场的相当大一部分，特别是在儿科护理中，减少不适感至关重要。同时，分光光度胆红素计正在迅速获得市场份额，以其在各种临床环境中的准确性和可靠性而受到认可。它们在医院中的日益应用展示了向先进诊断工具的强劲转变。

测量类型：经皮（主导）与光谱光度法（新兴）

经皮胆红素计是门诊和儿科环境中胆红素测量的基石，因其无创性和即时结果而受到青睐。其用户友好的设计使得快速评估成为可能，使其在紧急和常规评估中不可或缺。另一方面，光谱胆红素计虽然目前相对新兴，但由于其在多种临床环境中的优越准确性和适应性，正在迅速被采纳。随着医疗服务提供者越来越寻求精确的诊断解决方案，该细分市场的增长突显了在胆红素测量实践中整合先进技术的趋势。

### 按应用：新生儿筛查（最大）与黄疸监测（增长最快）

在胆红素计市场中，应用领域在三个关键领域之间表现出多样化的分布：新生儿筛查、黄疸监测和肝病诊断。目前，新生儿筛查占据最大份额，这归因于新生儿黄疸的发病率增加以及早期检测的重要性。黄疸监测虽然是一个较小的细分市场，但随着医疗专业人员对黄疸认识的提高，正在逐渐获得关注，推动了胆红素计在临床环境中的新安装和使用。
该市场细分的增长趋势受到技术进步和医疗支出增加的显著影响。对高效和非侵入性黄疸监测工具的需求促使了专门针对儿科的胆红素计设计的创新。此外，慢性肝病的增加推动了对准确肝病诊断的需求，从而支持了针对每个应用领域的胆红素计的持续产品开发。

新生儿筛查：显性与黄疸监测：新兴

新生儿筛查已成为胆红素计市场的主导应用，主要是由于对新生儿高胆红血症早期检测的迫切需求。医院和诊所越来越多地采用先进的胆红素计，以增强筛查过程，确保及时干预。这些仪器的技术进步使其能够在不需要侵入性程序的情况下提供快速结果，从而改善患者的舒适度和护理。另一方面，黄疸监测被认定为新兴细分市场，受到创新解决方案的推动，满足门诊环境的需求，并提高了人们对黄疸对健康影响的认识。该细分市场受益于向门诊护理和便携式监测解决方案的日益增长的趋势，满足了寻求即时结果的医疗服务提供者和家长的需求。

### 按准确性类别：标准准确性（最大）与高准确性（增长最快）

胆红素计市场在标准精度和高精度类别之间展示了显著的市场份额分布。标准精度仍然是最大的细分市场，因其在各种临床环境中的可靠性和成本效益而受到青睐。其已建立的市场地位确保了稳定的客户基础，确保了医院和医疗机构的持续需求。与此同时，高精度正在迎头赶上，受到对诊断精度日益增长的偏好的推动，特别是在需要严格测量协议的实验室和专科诊所中。随着技术的进步和对新生儿护理中胆红素测量重要性认识的提高，该细分市场正经历令人印象深刻的增长轨迹。医疗服务提供者越来越认识到，高精度设备提供更可靠的读数，从而改善患者的治疗结果。随着医疗环境的发展并强调高质量的诊断，对高精度胆红素计的需求预计将继续大幅上升，使其成为未来市场投资和创新的关键领域。

准确性类别：标准准确性（主导）与高准确性（新兴）

标准准确度的胆红素仪在医疗行业被广泛接受，提供了性能与经济性的平衡。其坚固的设计和易用性使其成为诊所和医院的主流，特别是在常规筛查中。然而，随着测量技术的进步和对患者护理准确性关注的加大，新的高准确度胆红素仪正在获得关注。这些设备利用复杂的算法和增强的光学技术，提供医疗专业人员在有效诊断和治疗中所需的精确结果。因此，高准确度在对精度要求极高的专业环境中迅速成为首选，标志着市场向更先进技术解决方案的关键转变。

### 按便携性：便携式胆红素计（最大）与医院内胆红素计（增长最快）

胆红素计市场在便携式和医院内胆红素计之间显示出显著的差异。便携式胆红素计因其便利性和在各种环境（包括居家护理和门诊环境）中的易用性而占据了最大的市场份额。相比之下，医院内胆红素计的采用速度迅速，尽管其整体市场份额较小。这一动态表明，对能够满足即时临床需求和长期患者管理场景的设备有着强烈的需求。
随着医疗保健继续强调门诊护理和患者监测，增长趋势反映出向更灵活和紧凑设备的转变。便携式胆红素计的推动因素是技术的进步，这些进步提高了准确性和可用性。与此同时，医院内胆红素计正在获得关注，因为医院在高科技解决方案上的投资使得快速和高效的患者检测成为可能，特别是在新生儿护理单位，及时干预至关重要。

便携式胆红素计：主导与住院胆红素计：新兴

便携式胆红素仪在胆红素仪市场中占据主导地位，因其在多种护理环境中的适应性和功能性而受到青睐。它们旨在提供快速准确的胆红素读数，便于在护理现场使用，使其在家庭医疗和门诊服务中极具价值。其用户友好的界面和无需复杂设置的操作能力促进了其广泛接受。相比之下，医院内胆红素仪在医院环境中逐渐成为重要工具，特别是在新生儿科。这些设备通常更为先进，集成了复杂算法和增强灵敏度等功能，旨在满足严格的临床环境需求。随着医院升级其诊断技术，对高性能医院内仪器的需求正在显著增长。

### 按患者人群：新生儿（最大）与成人（增长最快）

在胆红素计市场中，患者人群细分主要由新生儿主导，他们占据了市场的最大份额。他们对高胆红素血症的脆弱性导致了对可靠的胆红素测量设备在新生儿护理和医院中的持续需求。相比之下，成人和儿童的市场份额较小，但随着对胆红素相关疾病认识的提高，显示出显著的市场扩展潜力。

新生儿（主导）与成人（新兴）

新生儿是胆红素计市场的主要患者群体，这主要是由于他们对黄疸的高度敏感性以及定期监测的需求。新生儿护理单位配备了先进的胆红素计，以确保早期发现和治疗，这对婴儿健康至关重要。另一方面，成年人代表了这个市场中一个新兴的细分市场。虽然传统上被新生儿所掩盖，但肝病的日益普遍和对预防性医疗的日益重视正在推动成年人患者对胆红素计的需求。这个细分市场有望实现显著增长，受到强调早期诊断和干预的医疗趋势的影响。

## Regional Market Share Analysis

胆红素计市场分为北美、欧洲、亚太、南美以及中东和非洲。北美是胆红素计最大的市场，其次是欧洲。亚太地区预计在预测期内将以最高的复合年增长率增长。亚太地区的增长归因于中国和印度等国对胆红素计需求的增加。这些国家新生儿黄疸的高发病率推动了对胆红素计的需求。

南美市场预计在预测期内将以适度的速度增长。中东和非洲地区预计将见证最慢的增长，因为这些地区对胆红素计的认知度较低。

来源：初级研究，次级研究，_市场研究未来_数据库和分析师评审

## Competitive Benchmarking

胆红素计市场的主要参与者不断努力通过投资研发、扩展产品组合和加强分销渠道来获得竞争优势。领先的胆红素计市场参与者专注于开发创新技术，如非侵入性和床边胆红素计，以满足医疗专业人员和患者不断变化的需求。

胆红素计市场正在见证新进入者的出现和现有参与者的整合，塑造竞争格局。战略合作伙伴关系、合并和收购也在推动胆红素计市场的发展，因为公司寻求扩大其影响力并增强市场地位。胆红素计市场的领先公司之一，通用电气医疗，以其先进和可靠的胆红素计而闻名。

该公司的胆红素计 JM-105 在全球医院和诊所中广泛使用。通用电气医疗专注于提供满足医疗提供者特定需求的创新解决方案，如准确性、易用性和便携性。该公司对研发的承诺导致了尖端技术的发展，包括一种非侵入性胆红素计，提供快速和准确的结果。另一方面，德尔格作为胆红素计市场的领先竞争者，以其高质量和耐用的胆红素计而受到认可。

该公司的胆红素计 JM-103 以其准确性和可靠性而闻名，成为医疗专业人员的首选。德尔格强调提供全面的解决方案，以满足医院和诊所的多样化需求。该公司对客户满意度和技术创新的关注使其在市场上占据了强有力的立足点。德尔格对提供先进医疗技术的承诺继续推动其增长，并使其成为胆红素计市场中一个强大的竞争者。

## Recent News & Developments

- **2024年第二季度：柯尼卡美能达推出新型新生儿黄疸检测仪‘BiliCare Pro’** 柯尼卡美能达宣布推出其最新的新生儿黄疸检测仪‘BiliCare Pro’，该设备旨在进行非侵入性、即时的黄疸筛查。该设备具有更高的准确性和无线数据集成功能，可与医院电子健康记录系统对接。
- **2024年第一季度：Natus Medical宣布更新版NeoBlue黄疸检测仪获得FDA批准** Natus Medical获得FDA批准，更新版NeoBlue黄疸检测仪提供了更高的灵敏度和扩展的临床适应症，用于美国医院的新生儿黄疸监测。
- **2024年第二季度：飞利浦与联合国儿童基金会合作在东南亚部署黄疸检测仪** 飞利浦宣布与联合国儿童基金会合作，为东南亚的乡村诊所提供便携式黄疸检测仪，旨在改善服务不足地区新生儿黄疸的早期检测和治疗。
- **2024年第三季度：德尔格在德国开设新的医疗设备制造厂** 德尔格在德国吕贝克启用了一座新的医疗设备制造厂，专注于生产包括其最新系列黄疸检测仪在内的医疗设备，以供全球分销。
- **2024年第二季度：先进仪器推出下一代新生儿黄疸检测仪** 先进仪器推出了一款为新生儿重症监护病房量身定制的下一代黄疸检测仪，具有快速测量和改进的用户界面，方便临床工作人员使用。
- **2025年第一季度：Apel Co., Ltd.宣布与日本医院网络建立战略合作伙伴关系以部署黄疸检测仪** Apel Co., Ltd.与一家主要的日本医院网络建立了战略合作伙伴关系，计划在多个新生儿护理中心部署其最新的黄疸检测仪。
- **2025年第二季度：Reichert Technologies获得新型经皮黄疸检测仪的CE标志批准** Reichert Technologies获得新型经皮黄疸检测仪的CE标志批准，允许在欧盟范围内进行商业销售。
- **2024年第一季度：GINEVRI Srl推出便携式家庭用黄疸检测仪** GINEVRI Srl推出了一款便携式黄疸检测仪，旨在用于家庭监测新生儿黄疸，目标用户为家长和儿科医生，以便于早期干预。
- **2024年第三季度：Mennen Medical获得以色列卫生部的黄疸检测仪供应合同** Mennen Medical赢得了一项政府合同，为以色列卫生部运营的医院和诊所提供黄疸检测仪。
- **2025年第二季度：德尔格宣布高管任命：新任黄疸检测仪部门负责人** 德尔格任命安娜·穆勒博士为新任黄疸检测仪部门负责人，负责产品开发和全球市场战略。
- **2025年第一季度：先进仪器有限责任公司在美国扩大黄疸检测仪生产能力** 先进仪器有限责任公司宣布扩大其美国生产设施，以满足北美对其黄疸检测仪日益增长的需求。
- **2024年第二季度：Natus Medical Incorporated赢得与美国大型医院系统的黄疸检测仪供应合同** Natus Medical获得了一项供应合同，为美国一家大型医院系统提供其黄疸检测仪，扩大其在新生儿护理领域的市场份额。

## Report Scope

| 2024年市场规模 | 750.18（美元十亿） |
| --- | --- |
| 2025年市场规模 | 782.0（美元十亿） |
| 2035年市场规模 | 1184.77（美元十亿） |
| 年复合增长率（CAGR） | 4.24%（2024 - 2035） |
| 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 |
| 基准年 | 2024 |
| 市场预测期 | 2025 - 2035 |
| 历史数据 | 2019 - 2024 |
| 市场预测单位 | 美元十亿 |
| 主要公司简介 | 市场分析进行中 |
| 覆盖的细分市场 | 市场细分分析进行中 |
| 主要市场机会 | 先进非侵入性技术的整合提高了胆红素计市场的准确性。 |
| 主要市场动态 | 胆红素计的技术进步推动了竞争动态，并提高了医疗环境中的诊断准确性。 |
| 覆盖的国家 | 北美、欧洲、亚太、南美、中东和非洲 |

## Frequently Asked Questions

**Q: 截至2024年，胆红素计市场的当前估值是多少？**
A: 2024年胆红素计市场的价值为7501.8亿美元。

**Q: 2035年胆红素计市场的预计市场规模是多少？**
A: 预计到2035年，市场将达到1184.77亿美元。

**Q: 在2025年至2035年的预测期内，胆红素计市场的预期CAGR是多少？**
A: 预计2025年至2035年间，胆红素计市场的年均增长率（CAGR）为4.24%。

**Q: 在胆红素计市场中，哪些公司被视为关键参与者？**
A: 市场上的主要参与者包括飞利浦、雅培、罗氏、美敦力、Natus Medical、GlucoTrack、德尔格、Bionime 和 Ameda。

**Q: 根据测量类型，胆红素计市场的主要细分领域是什么？**
A: 主要细分市场包括经皮胆红素计、分光光度法胆红素计和化学试纸胆红素计。

**Q: 不同测量类型在胆红素计市场的估值如何比较？**
A: 经皮胆红素计量仪的价值为3200亿美元，分光光度计为4000亿美元，化学试纸条为4647.7亿美元。

**Q: 哪些应用正在推动胆红素计市场的增长？**
A: 主要应用包括新生儿筛查、黄疸监测和肝病诊断。

**Q: 在胆红素计市场中，黄疸监测的估值是多少？**
A: 黄疸监测的价值为4800亿美元。

**Q: 市场按精度等级细分的表现如何？**
A: 高精度细分市场的价值为704.77亿美元，而标准精度的价值为480.0亿美元。

**Q: 便携式与医院内胆红素计的预计增长是多少？**
A: 便携式胆红素计预计将达到4800亿美元，而医院内胆红素计预计将达到7047.7亿美元。


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/bilirubin-meter-market-31160*